Search

The article describes the case of a two-week old neonate with umbilical mass diagnoses as umbilical granuloma. It describes differential diagnosis for umbilical mass include ectopic tissue, umbilical polyp, patent omphalomesenteric duct, patent urachus, omphalomesenteric or urachal cyst, umbilical hernia, omphalocele, gastroschisis and omphalitis. Proposed treatments include silver nitrate, surgical excision and the topical corticosteroid clobetasol.

The article discusses the importance of consent for newborn screening issues. Topics discussed include newborn screening without consent with state statutes mandating phenylketonuria (PKU) screening in the 1960s, recommendation of National Academy of Sciences (NAS) expert committee for informed consent to be a prerequisite for newborn screening, and absence of entity to require new ideas in newborn screening to be tested prior and with no requirement for scientific studies or informed consent.

The article focuses on Mumbai, India-based genetic diagnostic and research company Navigene Genetic Science, founded by Rishi Dixit and Vrushali Joshi. It is mentioned that the company collects urine samples of newborns from hospitals and paediatric clinics across six major cities and tests them at its lab in Maharashtra, India.

The article offers information on a notice of proposed amendments on newborn metabolic screening and treatment code by the department of public health in Illinois. Amendments related to collection of blood and submission of specimens, diagnosis and treatment are also presented which include definitions of several terms such as advisory committee, department and director.

The article focuses on the evaluation and treatment of causes of stridor, a congenital abnormality associated with fever, in infants especially neonates. It indicates that stridor has an infectious, noninfectious and congenital origin. It describes various causes including croup, bacterial tracheitis and epiglottitis of stridor based on radiographic evaluation.

The article presents a diagnosis of the newly born infant who had significant abdominal distention that extend from the right upper quadrant to the right pelvis. The infant has undergone abdominal computed tomography (CT) scan and plain chest radiograph, which show a large radiograph mass on the left and right upper quadrants. The patient was diagnosed with infantile hepatic hemangioendothelioma, one of the most common hepatic tumor in neonates.

Focuses on the diagnosis of hypercalcemia in children. Symptoms exhibited by a hypotonic patient prior to the diagnosis of hypercalcemia; Advice for pediatricians on responding to the high calcium level of a patient; Application of subcutaneous fat necrosis and sclerema neonatorum in diagnosing a newborn with subcutaneous firm nodules.

Provides information on universal newborn screening. Description of newborn screening; Disorders that can be identified by tandem mass spectrometry; Issues involved in the cost analysis of newborn screening.

Discusses several newborn screening techniques for metabolic diseases. Cause of metabolic diseases; Challenges of diagnosing metabolic diseases; Treatments for metabolic diseases; Information on the newborn testing method developed by the Duke University Medical Center.

Discusses the use of tandem mass spectrometry (MS/MS) in screening newborn babies for treatable metabolic disorders. Discussion on metabolic disorders; Information on phenylketonuria; Details of the tandem mass spectrometry; Brief background on various children diagnosed with treatable metabolic disorder. INSETS: Michael Metil;Tangi Perdue;Baily Sciss;Andrew Plaisted

Part I. Presents an overview of newborn screening in the United States. Descriptions of the common tested disorders; Reasons why screening have not always been performed; Information on tandem mass spectrometry, a method used in newborn screening. INSET: Glossary.

Deals with the availability of a technology which makes it possible to test for rare deadly diseases in newborn babies. Functionality of tandem mass spectrometry; Treatments for inborn errors of metabolism; Obstacles to newborn health screening.

The article reports on the challenge for dermatologists to determine the extent of vascular birthmarks that affect newborns. According to the article, vascular birthmarks are common among babies, with some varieties affecting almost 50 percent of the newborns. University of California assistant professor of clinical dermatology and pediatrics, division of pediatric dermatology, Kelly M. Cordoro explained the importance of timely distinction between port wine stains, infantile hemangioma and salmon patches.

The article discusses the case of a 2-month-old girl with weight loss diagnosed with multiple hepatic masses or hemangioendotheliomas during abdominal ultrasonography. It cites that the girl has an account of physiological jaundice and gastroesophageal reflux (GER) and continues to vomit despite treatment with ranitidine. It offers information on its diagnosis, evaluation and workup, and treatment options for symptomatic patients including embolization therapy and corticosteroid treatment.

This article discusses a report by the March of Dimes that found only five states that screen for 29 rare but treatable conditions in newborn babies, including impaired hearing to hypothyroidism. Many of the conditions can be treated if found early. Only Maryland, Iowa, Mississippi, Virginia, New Jersey and the District of Columbia test for the conditions in newborns.

Opinion. Focuses on the issue of babies who are routinely tested for HIV in order to track the AIDS epidemic. Mothers who are not told the results; How some lobbies consider HIV testing an invasion of the mother's privacy; Reference to Pulitzer Prize-winning commentary by Jim Dwyer in `New York Newsday' on HIV-infected babies; Argument that test results should be made available so babies can receive proper medical attention.

The article offers information about the health screening tests to be performed on newborn babies to check if they are healthy. These include the Apgar Score observation test, the otoacoustic emissions test, the jaundice check, the pulse oximetry screening, and the newborn screening or heel-prick test.

The article discusses the case of a neonate born with congenital abnormalities that were consistent with Bart's syndrome. The mother was given desloratadine 5mg and montelukast 10mg tablets and beclometasone/formoterol aerosol during her pregnancy. The health conditions of both mother and neonate and treatment given are mentioned.

The article elaborates on public health genomics. Topics discussed include integration of genomics into the three core public health functions of policy development, assurance and assessment as well as areas of ongoing progress in genomics on newborn screening, family health history, pathogen genomics and genome sequencing in healthcare. Also mentioned are the U.S. Precision Medicine Initiative and the need for an active collaboration among sectors such as research, practice and public health.

The article offers guidelines for pediatricians to treat neonatal sepsis. It offers information on sepsis which is a blood infection affecting infants below 90-days-old. It discusses the etiology of sepsis which is attributed to Streptococcus bacteria or Escherichia coli. It also enumerates the signs and symptoms of pediatric sepsis and stresses the importance of timely appropriate treatment.

The article focuses on funding received by researchers from the University of Exeter to develop a test that identifies babies with neonatal diabetes, and mentions project leader Tim McDonald's views on death of babies due to late diagnosis of neonatal diabetes.

The article focuses on newborn screening through the use of bloodspot research to determine potential diseases in a newly born child in the U.S. It states that failure to detect and provide appropriate treatment for premature disorders shortly after birth might lead to mental retardation or early death. According to executive director Michael S. Watson at American College of Medical Genetics, the accessibility to residual dried blood spots is essential in the development of newborn screening.

The article focuses on Save Babies Through Screening Foundation Inc. (SBTS). It notes that the mission of SBTS is to improve babies' lives, prevent disabilities and death leading from disorders detectable by Newborn Screening and addressing issues like insurance coverage for medical formulas, vital supplements and residual dried blood spots (DBS). It cites that SBTS partnered with Bailey Baio Angel Foundation to make a Public Service Announcement (PSA) as part of their new strategic initiatives.

Provides information on screening tests for newborn babies in Australia. Collection of blood sample for laboratory analysis; Hereditary factor in diseases; Recognition of health problems in newborns.

Discusses infant screening tests for pregnant women in the United States (U.S.). Significance of the early detection of metabolic disorders in infants; Metabolic disorders which can be diagnosed with infant screening tests; Ways by which pregnant women can avail of screening tests; Reason for the differences in the guidelines on infant screening tests.

The article presents a case study of 15 newborn infants who developed various toxicities after receiving infusions of alprostadil for duct-dependent congenital heart disease (CHD).

Reports that newborns in some 44 states of the United States are tested automatically for HIV tests, mostly for statistical purposes and no one, including parents, can get individual results. Introduction of the Newborn HIV Notification Act in Congress.

The article reports on the findings of a multicenter study, published in the journal " JAMA Ophthalmology," which emphasize the efficacy of telemedicine for screening retinopathy (ROP) in newborn infants.

The article offers the insight of doctor Rick Stafford, director of Neonatology at Northern Westchester Hospital, regarding the importance of pulse oximetry assessment in examining newborns for potentially fatal disorders before leaving the hospital.

The article reports on the move of Johns Hopkins Children's Center to launch a free mobile application to help clinicians and parents of newborn infants screen rare liver disease called biliary atresia.

The article informs that researchers at the Nationwide Children's Hospital Inc. and University of Utah, Salt Lake City, Utah, have developed an approach to newborn screening for the life-threatening genetic disorder, Duchenne muscular dystrophy and potentially other muscular dystrophies.

The article offers information on the kind of thermometers for newborn infants or babies. Teardrop-shaped digital thermometers use electronic heat sensors to take readings in seconds. An infrared ray to measure the temperature of the inner-ear canal is used by the Graco 1-Second Ear Thermometer. Furthermore, rapid accurate temperature establishment (RATE) technology is employed by temple thermometer.

The article presents information by Piero Rinaldo, professor of laboratory medicine and pathology at Mayo Clinic in Rochester, Minnesota, about the screening of newborn infants for various diseases in the U.S. Rinaldo says that the next generation of newborn disorders includes severe combined immunodeficiency. Articles written by Rinaldo including, "Newborn Screening of Metabolic Disorders: Recent Progress and Future Developments," are also mentioned.

The article discusses the significance of newborn screening upon diagnosis of cystic fibrosis. It references a study published in the December 15, 2008 issue of "American Journal of Respiratory and Critical Care Medicine." The study shows that newborn screening indicates normal lung function of infants with cystic fibrosis. Dr. Barry M. Linnane of Royal Children's Hospital in Melbourne, Victoria concludes that there could be a window of opportunity during the first six months of the infant to intervene and possibly maintain normal lung function.

The article discusses a study on the benefits of newborn screening for cystic fibrosis. Great Britain-based researchers found that the screening is associated with improved clinical outcomes and lower costs versus diagnosis. They assert that the availability of estimated cost saving in the country in 2002 could have offset a significant part of the estimated cost of running a newborn screening program. Information on data obtained from the UK Cystic Fibrosis Database for the study is presented.

Presents a response by Jennifer Twente and Richard Strauss to a letter to the editor about their article "A Rapidly Deteriorating Baby Girl: Can You Judge This Book By Its Cover?," in the June 2005 issue.

Presents a letter to the editor in response to the article "A Rapidly Deteriorating Baby Girl: Can You Judge This Book By Its Cover?," by Jennifer Twente and Richard Strauss in the June 2005 issue.

Discusses research being done on neonatal screening for congenital disorders. Reference to study by M. Natowicz, published in the September 1, 2005 issue of the "New England Journal of Medicine." Inadequacies and unevenness in clinical follow-up and care for neonates with congenital disorder; Importance of neonatal screening.

Answers some of the most common questions of parents about newborn screening tests on infants. Tests received by the infant in newborn screening; Inquiry about the results; Action taken by the medical personnel if the tests are positive.

Provides information regarding the screening of newborn infants for genetic disorders in the U.S.

Presents news briefs concerning pediatrics in the U.S. as of November 2004. Issuance of a statement by pediatricians against the tax and budget policies of the government; Complaints against the Food and Drug Administration; Recommendation for medical screening of newborns for various genetic disorders.

Reports that U.S. newborns are subjected to a hearing test before they leave the hospital. Significance of such action.

Focuses on the significance of screening tests for newborn babies. Disorders diagnosed in newborn.

Reports on a law in Colorado that requires second screening of babies seven to fourteen days after birth for purposes of preventing serious health problems.

Abstracts the article `HIV Serosurveillance of Newborns: A Clinician's Perspective on Legislative, Political, and Ethical Issues,' by C. Garret, originally published in the `Journal of Substance Abuse Treatment.'

Reports that researchers have found that recording babies' movements yielded more accurate predictions of brain damage than did ultrasound measures. Findings of the study conducted on newborn infants by Heinz F.R. Prechtl and his colleagues, of Karl Franzens University of Graz, Austria; Report as presented in the May 10, 1997 `Lancet.'

Reports on the recommendation of Australian acquired immunodeficiency virus (AIDS) experts concerning education on the benefits of AIDS testing during pregnancy. Statistics on the number of children born to AIDS positive women in Australia.

Reports that New York governor George Pataki announced that the state will be allowing mothers to learn the results of HIV antibody tests routinely administered to newborns.